Loading...
Loading...
Denmark's Novo Nordisk A/S
NVO posted a 28% rise in its first-quarter net profit and lifted its full-year forecast.
Novo Nordisk raised its 2013 sales growth forecast to 9% to 11% in local currencies, versus 8% to 11%.
Novo Nordisk's quarterly net profit surged 28% to DKK5.98 billion, from DKK4.66 billion, in the year-ago period.
Its sales climbed 13% to DKK19.98 billion from DKK17.75 billion. However, analysts were expecting a profit of DKK5.85 billion on sales of DKK19.76 billion.
Its operating profit climbed to DKK7.56 billion from DKK6.39 billion.
Novo Nordisk shares closed at $176.63 yesterday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in